{"url_path":"/sec/ndra/10-q/2026/item-1a","section_key":"item-1a","section_title":"Item 1A Risk Factors**","topic":"sec","document":{"doc_type":"10-Q","doc_date":"2026-05-15","source_url":"https://www.sec.gov/Archives/edgar/data/1681682/0001213900-26-057680-index.html","accession_number":"0001213900-26-057680","cik":"0001681682","ticker":"NDRA","issuer_name":"ENDRA Life Sciences Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1681682/0001213900-26-057680-index.html","primary_entity_key":"0001681682","primary_entity_name":"ENDRA Life Sciences Inc."},"word_count":111,"has_tables":true,"body_markdown":"**Item 1A. Risk Factors**\n\n \n\nIn addition to the other information set forth\nin this report, you should carefully consider the factors discussed in this section and under “Risk Factors” in our Annual\nReport on Form 10-K for the period ended December 31, 2025, as filed with the Securities and Exchange Commission on March 31, 2026. These\nfactors could materially adversely affect our business, financial condition, liquidity, results of operations and capital position, and\ncould cause our actual results to differ materially from our historical results or the results contemplated by any forward-looking statements\ncontained in this report.\n\n \n\nThere have been no material changes to our Risk Factors as therein\npreviously reported."}